These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 7704084

  • 1. Catechol estrogens are more potent antioxidants than estrogens for the Cu(2+)-catalyzed oxidation of low or high density lipoprotein: antioxidative effects of steroids on lipoproteins.
    Taniguchi S, Yanase T, Kobayashi K, Takayanagi R, Haji M, Umeda F, Nawata H.
    Endocr J; 1994 Dec; 41(6):605-11. PubMed ID: 7704084
    [Abstract] [Full Text] [Related]

  • 2. Estrogens inhibit copper and cell-mediated modification of low density lipoprotein.
    Mazière C, Auclair M, Ronveaux MF, Salmon S, Santus R, Mazière JC.
    Atherosclerosis; 1991 Aug; 89(2-3):175-82. PubMed ID: 1793445
    [Abstract] [Full Text] [Related]

  • 3. The inhibition of low-density lipoprotein oxidation by 17-beta estradiol.
    Rifici VA, Khachadurian AK.
    Metabolism; 1992 Oct; 41(10):1110-4. PubMed ID: 1328822
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Inhibition of LDL oxidation by a new estradiol receptor modulator compound LY-139478, comparative effect with other steroids.
    Rattan AK, Arad Y.
    Atherosclerosis; 1998 Feb; 136(2):305-14. PubMed ID: 9543102
    [Abstract] [Full Text] [Related]

  • 7. Superior and distinct antioxidant effects of selected estrogen metabolites on lipid peroxidation.
    Tang M, Abplanalp W, Ayres S, Subbiah MT.
    Metabolism; 1996 Apr; 45(4):411-4. PubMed ID: 8609824
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Concentration dependence of prooxidant and antioxidant properties of catecholestrogens.
    Markides CS, Roy D, Liehr JG.
    Arch Biochem Biophys; 1998 Dec 01; 360(1):105-12. PubMed ID: 9826435
    [Abstract] [Full Text] [Related]

  • 11. Magnoflorine from Coptidis Rhizoma protects high density lipoprotein during oxidant stress.
    Hung TM, Lee JP, Min BS, Choi JS, Na M, Zhang X, Ngoc TM, Lee I, Bae K.
    Biol Pharm Bull; 2007 Jun 01; 30(6):1157-60. PubMed ID: 17541173
    [Abstract] [Full Text] [Related]

  • 12. Mangostin inhibits the oxidative modification of human low density lipoprotein.
    Williams P, Ongsakul M, Proudfoot J, Croft K, Beilin L.
    Free Radic Res; 1995 Aug 01; 23(2):175-84. PubMed ID: 7581813
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Inhibition of human low density lipoprotein and high density lipoprotein oxidation by oligostilbenes from rhubarb.
    Ngoc TM, Hung TM, Thuong PT, Na M, Kim H, Ha do T, Min BS, Minh PT, Bae K.
    Biol Pharm Bull; 2008 Sep 01; 31(9):1809-12. PubMed ID: 18758083
    [Abstract] [Full Text] [Related]

  • 15. Antioxidant protection of LDL by physiologic concentrations of estrogens is specific for 17-beta-estradiol.
    Shwaery GT, Vita JA, Keaney JF.
    Atherosclerosis; 1998 Jun 01; 138(2):255-62. PubMed ID: 9690908
    [Abstract] [Full Text] [Related]

  • 16. Prooxidant activity of caffeic acid, dietary non-flavonoid phenolic acid, on Cu2+-induced low density lipoprotein oxidation.
    Yamanaka N, Oda O, Nagao S.
    FEBS Lett; 1997 Mar 24; 405(2):186-90. PubMed ID: 9089288
    [Abstract] [Full Text] [Related]

  • 17. Protective effect of lipoproteins containing apoprotein A-I on Cu2+-catalyzed oxidation of human low density lipoprotein.
    Ohta T, Takata K, Horiuchi S, Morino Y, Matsuda I.
    FEBS Lett; 1989 Nov 06; 257(2):435-8. PubMed ID: 2511042
    [Abstract] [Full Text] [Related]

  • 18. Age-related decrease of dehydroepiandrosterone concentrations in low density lipoproteins and its role in the susceptibility of low density lipoproteins to lipid peroxidation.
    Khalil A, Fortin JP, LeHoux JG, Fülöp T.
    J Lipid Res; 2000 Oct 06; 41(10):1552-61. PubMed ID: 11013296
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Atorvastatin and gemfibrozil metabolites, but not the parent drugs, are potent antioxidants against lipoprotein oxidation.
    Aviram M, Rosenblat M, Bisgaier CL, Newton RS.
    Atherosclerosis; 1998 Jun 06; 138(2):271-80. PubMed ID: 9690910
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.